Fat cell therapy shows promise for knee arthritis
NCT ID NCT07112885
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tested whether combining a knee surgery (microfracture) with an injection of cells from the patient's own fat (SVF) works better than the injection alone for knee osteoarthritis. Fifty people with moderate knee arthritis took part. The researchers measured pain, knee function, and cartilage changes using MRI over two years.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Stromal vascular fraction (SVF) from the patient's own fat tissue
- What this could lead to
- If successful, this combination could offer a better way to reduce pain and improve knee function in people with knee osteoarthritis.
- What could go wrong
- This is a small, early-stage trial with only 50 participants. The results may not apply to everyone, and the long-term benefits or risks are still unknown.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
50 people
The number who actually took part.
- Started
-
Feb 2023
- Finished
-
May 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
49 to 71 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients with stage II-III osteoarthritis of the knee * Patients with a mechanical axis deviation not exceeding 15 mm on the anteroposterior orthoroentgenogram x-ray Exclusion Criteria: * Patients with deformities on anteroposterior and lateral x-ray examinations * Patients with a BMI greater than 35 kg/m2 * Patients diagnosed with secondary gonarthrosis (Rheumatoid arthritis, secondary to trauma) * Patients with a history of intra-articular injections within the last 6 months * Patients with a history of knee joint surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Knee osteoarthritis (knee oa) are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Istanbul University Faculty of Medicine
Istanbul, 34320, Turkey (Türkiye)
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your own blood cells boost knee pain relief?
- Can your own blood cells boost knee injection therapy?
- Can ancient ayurvedic remedies outperform modern medicine for knee pain?
- Can a pain drug help you walk better with knee arthritis?
- Can a booklet boost knee surgery recovery?
- Can a simple pressure-sensing device beat foam rolling for knee arthritis pain?